Sofosbuvir/Ledipasvir for HCV in Children Aged 3-6 Years Sofosbuvir/Ledipasvir for HCV in Children Aged 3-6 Years

The use of interferon-based regimens in chronic hepatitis C-infected children 3-6 years of age is limited due to side effects. Does sofosbuvir/ledipasvir therapy provide a safe alternative?Liver International
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news